
Sign up to save your podcasts
Or
Håvard Skjerven and Karin Lødrup Carlsen discuss their follow-up study to the bronchiolitis ALL trial, which suggests that giving inhaled epinephrine for acute bronchiolitis in children does not confer benefit, even for those at risk of allergic disease.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
5
11 ratings
Håvard Skjerven and Karin Lødrup Carlsen discuss their follow-up study to the bronchiolitis ALL trial, which suggests that giving inhaled epinephrine for acute bronchiolitis in children does not confer benefit, even for those at risk of allergic disease.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
131 Listeners
3,193 Listeners
2,053 Listeners
3 Listeners
325 Listeners
34 Listeners
4 Listeners
37 Listeners
496 Listeners
111,917 Listeners
1,095 Listeners
349 Listeners
23 Listeners
0 Listeners
0 Listeners
58,143 Listeners
2 Listeners
1 Listeners
0 Listeners
13,053 Listeners
1 Listeners
0 Listeners
0 Listeners
1 Listeners
0 Listeners
0 Listeners
1 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners